Dexcom Inc. is a leading medical device company focused on the development and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes. Its mission is to empower individuals to manage their diabetes more effectively through innovative technology that provides real-time glucose data. Dexcom's strategy emphasizes research and development to enhance its product offerings, expand market reach, and improve patient outcomes. The company's operations involve the design, manufacturing, and distribution of CGM devices that enable users to monitor their glucose levels seamlessly, ultimately aiming to improve the quality of life for those living with diabetes.

DEXCOM INC

DexCom has recently launched its first over-the-counter continuous glucose monitor (CGM) called Stelo, marking a significant expansion in its product offerings targeted at both insulin-dependent and non-diabetic users. Stelo, which received FDA approval back in March 2023, is now available for purchase without a prescription, priced at $99 for a...

DexCom Launches Over-the-Counter Continuous Glucose Monitor Stelo, Targeting Type 2 Diabetes and Prediabetes Markets